Yu He, Zehua Ying, Yanbin Xie, Wei He*
Department of Pain Management, Mianyang Central Hospital, Mianyang, Sichuan 621000, China
Introduction: Neuromodulation is technology that acts directly upon nerves. It is the alteration, or modulation, of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. In this study, neuromodulation was applied in 61 patients with refractory pain to clarify its clinical efficacy.
Materials and methods: A total of 122 refractory pain patients treated in our hospital from January 2018 to January 2021 were chosen as research subjects and were divided into 2 groups using random number table method, namely control group and observation group, with 61 cases in each group. The control group received treatment with conventional analgesic drugs. The observation group received additional treatment with neuromodulation technology. The pain score, activity of daily living (ADL) score, depression score, anxiety score, clinical efficacy, adverse reactions, and compliance rate between groups before treatment and 1 month after treatment were assessed.
Results: The pain score, activity of daily living (ADL) score, depression score, anxiety score, clinical efficacy, adverse reactions, and compliance rate presented no difference between two groups. After treatment, these indexes in observation group presented a better result relative to those in the control group.
Conclusion: Neuromodulation has a marked clinical efficacy in treating refractory pain. In addition to effectively reducing the degree of pain, it can also effectively improve patient's psychological state and elevate their ADL.
Neuromodulation technology, refractory pain, clinical efficacy, clinical research.